Floatz logo

Zofran

Cutaneous Lymphoma

UNC Lineberger Comprehensive Cancer CenterPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Cutaneous Lymphoma cohort.

Asset / SponsorPhaseRating
Brentuximab Vedotin
M.D. Anderson Cancer Center
Phase 2B
Vorinostat
Stanford University
Phase 1/2CCC
(+)-VINCRISTINE
Stanford University
Phase 1/2CCC
Irinotecan
Stanford University
Phase 1/2CCC
Inno-206
Weiyun Ai
Phase 1CC

View all 13 →

Same molecule, other indications

Zofran is also rated in:

NauseaDormant
BBB
Indicative ·
73 / 100
View asset →
VomitingDormant
BBB
Indicative ·
73 / 100
View asset →
Non-Hodgkin's LymphomaDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →